PRELUDE CAPITAL MANAGEMENT, LLC - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 28 filers reported holding HORIZON PHARMA INVT LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q1 2017$1,327,000
-4.3%
1,450,0000.0%0.13%
-24.4%
Q4 2016$1,387,000
+662.1%
1,450,000
+625.0%
0.17%
+572.0%
Q2 2016$182,000
+6.4%
200,0000.0%0.02%
+4.2%
Q1 2016$171,000200,0000.02%
Other shareholders

There were no reported owners of HORIZON PHARMA INVT LTD in Q3 2016.

NameSharesValueWeighting ↓
View complete list of HORIZON PHARMA INVT LTD shareholders